Habib Bouzina
Overview
Explore the profile of Habib Bouzina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjellstrom B, Bouzina H, Bjorklund E, Beaudet A, Edwards S, Hesselstrand R, et al.
ESC Heart Fail
. 2022 Jul;
9(5):3264-3274.
PMID: 35789127
Aims: Repeated risk assessments and treatment patterns over long time are sparsely studied in chronic thromboembolic pulmonary hypertension (CTEPH); thus, we aimed to investigate changes in risk status and treatment...
2.
Arvidsson M, Ahmed A, Bouzina H, Radegran G
ESC Heart Fail
. 2021 Jan;
8(2):1230-1243.
PMID: 33403810
Aims: Right ventricular dysfunction may arise because of pulmonary arterial hypertension (PAH). Development of new diagnostic methods able to identify PAH and allow for earlier treatment initiation, before the development...
3.
Bouzina H, Radegran G, Butler O, Hesselstrand R, Hjalmarsson C, Holl K, et al.
ESC Heart Fail
. 2020 Dec;
8(1):680-690.
PMID: 33305545
Aims: Low-risk status in pulmonary arterial hypertension (PAH) predicts better survival. The present study aimed to describe changes in risk status and treatment approaches over multiple clinical assessments in PAH,...
4.
Ahmed S, Ahmed A, Bouzina H, Lundgren J, Radegran G
Heart Vessels
. 2020 Jul;
35(11):1614-1628.
PMID: 32651845
Background: The prevalence of heart failure (HF) is rising with ageing population and constitutes a major health problem globally. A common complication of HF is pulmonary hypertension (PH) which negatively...
5.
Bouzina H, Hesselstrand R, Radegran G
Scand Cardiovasc J
. 2020 Jun;
55(1):35-42.
PMID: 32597241
Beside the pulmonary vasoconstriction observed in pulmonary arterial hypertension (PAH), severe proliferative and antiapoptotic cellular phenotypes result in vascular remodelling. Many recent findings indicate similarities between PAH and tumour pathology....
6.
Bouzina H, Radegran G
Pulm Circ
. 2020 Jun;
10(3):2045894020931317.
PMID: 32595932
Adrenomedullin is a potent vasodilatory peptide, linked to pulmonary arterial hypertension pathology. Proximity extension assays were utilized to study plasma biomarkers related to vasoregulation, with focus on adrenomedullin peptides and...
7.
Ahmed A, Ahmed S, Arvidsson M, Bouzina H, Lundgren J, Radegran G
ESC Heart Fail
. 2020 Jun;
7(5):2340-2353.
PMID: 32548968
Aims: Metabolic derangement is implicated in the pathophysiology of heart failure (HF) and pulmonary hypertension (PH). We aimed to identify the dynamics of metabolic plasma proteins linked to end-stage HF...
8.
Ahmed S, Ahmed A, Saleby J, Bouzina H, Lundgren J, Radegran G
Heart Vessels
. 2020 Jan;
35(6):786-799.
PMID: 31960146
Receptor tyrosine kinases (RTKs) are implicated in cardiovascular growth and remodelling. We aimed to identify the plasma levels of RTKs and related proteins and their association with haemodynamic alterations in...
9.
Bouzina H, Hesselstrand R, Radegran G
Pulm Circ
. 2020 Jan;
9(4):2045894019895446.
PMID: 31908768
Metabolic abnormalities are proposed to contribute to pulmonary arterial as well as right ventricular remodelling in pulmonary arterial hypertension. Among the proposed abnormalities are altered glucose and lipid processing, mitochondrial...
10.
Arvidsson M, Ahmed A, Bouzina H, Radegran G
Pulm Circ
. 2020 Jan;
9(4):2045894019895414.
PMID: 31908766
Pulmonary arterial hypertension is a severe disease for which diagnosis often is delayed. Matrix metalloproteinases have been suggested to play a role in vascular remodeling and pulmonary hypertension development. Our...